A Strategy Focused on Care and Scale
Managing Partner Richard Park said the firm’s mission extends beyond financial returns.
“We invest in and support efforts designed to strengthen healthcare quality, expand access, and improve patient outcomes,” Park said. He added that Ascend’s operating expertise and in-house resources allow it to collaborate closely with physicians and executives to improve clinical performance, bolster compliance and documentation integrity, and build platforms positioned for long-term impact.
The fund has already begun deploying capital, backing companies including Seoul Medical Group and Unison Therapy Services, according to the firm’s statement.
Broad Investor Backing
Ascend Capital Partners Fund II drew support from a wide range of both new and returning limited partners. The investor base includes public and private pension funds, foundations, endowments, consultants, family offices and funds of funds — a cross-section of institutional capital signaling confidence in the firm’s healthcare thesis.
Managing Partner In Seon Hwang thanked investors for their backing, calling it a reflection of trust in the firm’s mission and performance.
“We look forward to building on our momentum and remain focused on partnering closely with physicians and management teams to build stronger healthcare organizations that improve patient outcomes while generating durable, long-term value,” Hwang said.
Full details regarding the Kirkland legal team advising Ascend were not immediately available Wednesday.
With nearly $800 million in fresh capital, Ascend’s latest fund positions the firm to deepen its footprint in a healthcare sector increasingly defined by value-based models, technology integration and the pursuit of measurable outcomes.
